KLÖCKNER PENTAPLAST ANNOUNCES $25M INVESTMENT IN CAPACITY EXPANSION IN NORTH AMERICA

Klöckner Pentaplast’s Pharma & Medical Device Division (kp PMD) announced that it will add to its global production capacity in North America.

This content was submitted directly to this website by the supplier.

“Our significant expansion plans reflect our dedication to servicing customers’ needs now, and in the future,” says Tracey Peacock, President kp PMD.The additional coating and laminating capability suitable for the production of Pentapharm® and Pentamed® packaging films will service the North American pharmaceutical and medical device industry. We are excited to support the growing high barrier product segments by investing in best in class coating and laminating capabilities, enabling newperformance levels in barrier protection.”

kp PMD is investing $25 million over the next few years in technology and processes to ensure they deliver innovative, functional and safe products for customers. This investment in North America complements earlier announcements by kp this year, highlighting their capacity expansions in Switzerland and Brazil. kp plans for the new capability in North America to be operational in 2020.

Visit the team at Healthcare Packaging Expo (part of Pack Expo), booth #864 from 14-17th October 2018 in Chicago, Illinois to learn more about kp PMD and their products.

Companies in this article
More in Home